Selected article for: "asymptomatic transmission and pandemic influenza"
Author: Dennis L Chao; Assaf P Oron; Devabhaktuni Srikrishna; Michael Famulare
Title: Modeling layered non-pharmaceutical interventions against SARS-CoV-2 in the United States with Corvid
  • Document date: 2020_4_11
    • ID: 3oovwwem_1
    Snippet: The United States has had nearly 400,000 tested or presumptive cases of COVID-19, the disease caused by the novel coronavirus SARS-CoV-2 [1] . At the time of writing, there are no approved pharmaceuticals to prevent or treat cases of SARS-CoV-2 infection. Therefore, the only available option to slow or even stop the epidemic is to use non-pharmaceutical interventions (NPIs), including school closures, workplace closures, quarantine, and other "so.....
    Document: The United States has had nearly 400,000 tested or presumptive cases of COVID-19, the disease caused by the novel coronavirus SARS-CoV-2 [1] . At the time of writing, there are no approved pharmaceuticals to prevent or treat cases of SARS-CoV-2 infection. Therefore, the only available option to slow or even stop the epidemic is to use non-pharmaceutical interventions (NPIs), including school closures, workplace closures, quarantine, and other "social distancing" measures. The effectiveness of NPIs has been studied mostly in the context of seasonal and pandemic influenza, but most of the evidence is based on modeling and simulation [2] [3] [4] . However, SARS-CoV-2 is not the same as influenza. SARS-CoV-2 is more transmissible, has a longer incubation period, and may have more asymptomatic transmission. Therefore, modeling will be a useful tool for evaluating the potential effectiveness of NPIs against SARS-CoV-2 epidemics.

    Search related documents:
    Co phrase search for related documents
    • asymptomatic transmission and epidemic stop: 1
    • asymptomatic transmission and incubation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • asymptomatic transmission and long incubation period: 1, 2, 3, 4, 5, 6, 7
    • asymptomatic transmission and non pharmaceutical intervention: 1, 2
    • asymptomatic transmission and potential effectiveness: 1, 2, 3
    • available option and incubation period: 1, 2
    • epidemic stop and incubation period: 1
    • incubation period and long incubation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • incubation period and non pharmaceutical intervention: 1, 2, 3
    • incubation period and pandemic seasonal influenza: 1
    • non pharmaceutical intervention and npi effectiveness: 1
    • non pharmaceutical intervention and NPIs non pharmaceutical intervention: 1, 2, 3, 4